AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05795738 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: traditional visuomotor training program
Description: this program includes play and paper-and-pencil activities, ipad games using commercial or self-designed stuffs as activity materials
Study NCT04770649 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 vaccine
Description: Any vaccine for COVID-19
Study NCT05452135 — intervention group
Intervention type: OTHER
Intervention: Observation of visual, audotory and motor reaction time
Description: Visual, auditory and motor reaction time will be measured as a result of the measurements made during the dual task evaluation.
Study NCT05024253 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid injection
Description: . TXA, a lysine analogue, reversibly binds to the plasminogen lysine receptors and thereby blocks plasminogen from binding to fibrin (tPA can only activate fibrin-bound plasminogen and produce plasmin responsible for cleaving fibrin molecule and dissolving the blood clot)
Study NCT04060316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLS-1200
Description: GLS-1200 is given as a nasal spray using an atomizer
Study NCT04060316 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is given as a nasal spray using an atomizer
Study NCT05637619 — intervention group
Intervention type: DEVICE
Intervention: Monolithic Zirconia
Description: Maxillary or/and mandibular screw retained zirconia monolithic prostheses supported by at least 4 implants
Study NCT05637619 — intervention group
Intervention type: DEVICE
Intervention: Hybrid-Acrylic
Description: Maxillary or/and mandibular screw retained hybrid prostheses supported by at least 4 implants;
Study NCT05637619 — intervention group
Intervention type: BEHAVIORAL
Intervention: Dentate Patients
Description: Dentate Patients with natural dentition or tooth supported crowns
Study NCT05541653 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Financial Well-being Interventions
Description: Tax preparation; access to public benefits; financial counseling and microgrants
Study NCT05541653 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Place-based Interventions
Description: Vacant lot greening; abandoned house remediation; trash cleanup; and tree planting.
Study NCT06399809 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisetin
Description: Fisetin is a flavanol, present in strawberries, apples, and persimmons, that destroys senescent cells (i.e. a senolytic therapy). Of three senolytic therapies being tested in clinical trials, fisetin has the best safety profile.
Study NCT06399809 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo will be matched to the Fisetin intervention
Study NCT05024253 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: mixture of sodium chloride (salt) and water in solution with 0.90% w/v of NaCl
Study NCT06041009 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pancreatic elastase-1 in blood serum
Description: Serum samples were collected from each patient to detect serum multiomics and pancreatic elastase-1 (PE-1). We examine multiomics in the pancreatic tissue collected from the patient who had undergone surgery or the necessary puncture examination and signed the informed consent form.
Study NCT05312840 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cisplatin / Carboplatin，Gemcitabine，Cindilimab
Description: 1. Routine dose group: Every three weeks as a cycle. On the first day of each cycle, Gemcitabine 1000mg / m2, Cisplatin 75mg / m2 / Carboplatin auc5 were injected intravenously, and Gemcitabine 1000mg / m2 and Cindilimab 200mg were injected intravenously on the eighth day; 2. Low dose group: every three weeks as a cycle. On the first day of each cycle, Gemcitabine 750mg / m2, Cisplatin 56mg / m2 / Carboplatin auc3 were injected intravenously 75. On the eighth day, Gemcitabine 750mg / m2 and Cindilimab 200mg were injected intravenously.
Study NCT05278845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SLC-391
Description: SLC-391 is an AXL inhibitor
Study NCT05252208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Description: Stretching (30-45 minutes, 5 days per week, 6 months)
Study NCT05252208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking exercise
Description: Walking (30-45 minutes, 5 days per week, 6 months)
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Colonoscopy
Description: The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard Colonoscopy
Description: The Standard Colonoscope is a high-definition colonoscope employing advanced optical filtering and enhancement techniques - blue light imaging (BLI) and linked color imaging (LCI).
Study NCT05127681 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: HR-pQCT
Description: Patients will have a unique HR-pQCT scanner imaging to study their bone microarchitecture
Study NCT05127681 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Patients will have a unique blood sampling of 10 mL for the measurements of sera PINP, CTX-I, periostin levels
Study NCT05127681 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Dual energy X-ray absorptiometry
Description: A dual energy X-ray absorptiometry scan of lumbar spine, hip, distal radius and whole body, body composition, lateral spine will be performed.
Study NCT05127681 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: medical data collection
Description: Data of healthy men is already available
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAD-EYE
Description: CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas.
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CAD-EYE
Description: CAD-EYE is an artificial intelligence software, used in real-time during the colonoscopy procedure for aiding the identification and characterization of polyps and adenomas.
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: G-EYE
Description: The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.
Study NCT05318495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: G-EYE
Description: The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning.
Study NCT06287021 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jump System Traser® cup
Description: Press-fit, cementless, 3D-printed, highly-porous trabecular titanium acetabular cup
Study NCT06287021 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Jump System HAX-Pore® cup
Description: Press-fit, cementless, hydroxyapatite/titanium plasma-sprayed acetabular cup
Study NCT06213207 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulator based training to manage asphyxia and essential newborn care using neonatalie
Description: The intervention, HBB training package will be used which was applied to train the hospitals staff in Nepal (Chaulagain et al., 2021) and Laerdal Global Health (Laerdal Global Health, 2021) to enhance the competencies on the resuscitation to newborn using NeoNatalie. Health workers will receive 5 days simulation training by expert pediatrician and pediatric nurse who have prior working experience in Neonatal Intensive Care Unit (NICU) or Special Neonatal Care Unit. After the training, mentoring and coaching will be provided experienced newborn coach/trainer on a monthly basis for six months.
Study NCT04514731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Description: Magnesium group receives magnesium sulfate (50 mg/kg) in 100 mL of isotonic saline over 15 minutes after spinal anesthesia, followed by a continuous magnesium sulfate infusion (15 mg/kg/hour) until the end of surgery.
Study NCT04514731 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic Saline
Description: Isotonic saline group receives the same volume of isotonic saline, administered according to the same methods as in the magnesium group.
Study NCT05343585 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PortionSize AI
Description: For this pilot study, using a convenience sample, the investigators will recruit up to 25 adults to use the Nutrition AI technology in Openfit to identify and estimate portion size of foods provided in a laboratory setting at Pennington Biomedical Research Center (PBRC) and/or Louisiana State University (LSU). Laboratory members within the Ingestive Behavioral Laboratory will also test the ability of Nutrition AI to identify foods and to quantify foods provided in the laboratory. Meals will be simulated, and participants will not consume the foods provided.
Study NCT05446623 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Opioid free anesthesia (OFA) consists in the simultaneous administration of alpha2-agonist (for example the dexmedetomidine), sodium channel blocker (lidocaine), and NMDA antagonists receptors (Ketamine). Its aim is to control de cardiovascular nociceptive response to the surgical stimulation.
Study NCT05446623 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sufentanil
Description: The one in the OA group will be given a bolus of Sufentanil before and during the surgery.
Study NCT04859101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gum
Description: 2 minutes of gum chewing prior to procedure
Study NCT04859101 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: 2 swallows prior to procedure
Study NCT06007508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine
Description: Long-acting insulin
Study NCT05906992 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CT-P53
Description: Intravenous(IV) infusion
Study NCT05906992 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: US-Ocrevus
Description: Intravenous(IV) infusion
Study NCT05906992 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: EU-Ocrevus
Description: Intravenous(IV) infusion
Study NCT06457113 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Attention Bias Modification and Targeted memory reactivation during REM sleep
Description: Emerging evidence shows that REM sleep is crucial for processing emotional memories and consolidating implicit memories. By using targeted memory reactivation (TMR), a known method where sound S1 and sound S2 are associated with a waking experience(i.e.negative emotional words is associated with alcohol-related cues and positive emotional words is associated with healthy lifestyle cues) and strengthened during REM sleep, the investigators aim to augment the control of craving levels in patients with Alcohol Use Disorder.
Study NCT06457113 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Attention Bias Modification
Description: These patients will receive the treatment of emotional attention bias modification (EABM) without association with the sound S1 and sound S2.
Study NCT04799002 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: Topotecan intraocular injection for chemotherapy in retinoblastoma
Study NCT04799002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Melphalan intraocular injection for chemotherapy in retinoblastoma
Study NCT06295380 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual environment practiced on the Caren
Description: The virtual environment practised on the Caren will make the scenario totally immersive and allow the subject to perform the motor task by recruiting muscles according to a motor coordination scheme different from the traditional one.
Study NCT06295380 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy
Study NCT05605730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maitland mobilization for thoracic spine
Description: The thoracic spine mobilization will be consisting of oscillations to the thoracic vertebrae from the prone positions for repeated 30 times with 1 min interval between each 4 sets for 15 minutes. For central posterio-anterior mobilization, a grade III large amplitude rhythmic oscillation in the postero-anterior direction will be applied to the joint sign segment which is defined as the patient's most painful or hardest to move segment. It will be detected through a passive accessory intervertebral motion (PAIVM) test. T6,7 will be used as a site for application if the joint sign can't be detected. The frequency of treatment sessions will be 3 sessions per week for 4 weeks.
Study NCT05605730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan thoracic sustained natural apophyseal glide (SNAGS)
Description: Verbal instructions will be provided for the patient to move into thoracic extension and do over-pressure at the end of ROM while a transverse glide is maintained by the therapist for a set of 10 repetitions. The significance of performing a pain-free movement will be emphasized to the patient all the time. There will be 3 sets of 10 repetitions with one minute rest between each set.
Study NCT05605730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional exercise management
Description: Prone back extension. Shoulder external rotation starting in 45° of internal rotation, with the arm by the side and the elbow flexed to 90 °.~Shoulder internal rotation starting in 45 ° of external rotation, with the arm by the side and the elbow flexed to 90 °..~Shoulder abduction (scapular plane) through a 0- to 60-° with the elbow flexed 90 ° and the shoulder in neutral rotation.~Shoulder flexion (sagittal plane) through a 0- to 60-°starting with the elbow flexed 90 ° and the shoulder in neutral rotation and punching forward, simultaneously extending the elbow and flexing the shoulder.~Internal rotation towel stretch: Subjects will be instructed to sit or stand while holding a towel with the affected arm behind the back and to use the other arm to pull the affected arm up the back.
Study NCT05605730 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional exercise management
Description: Prone back extension. Shoulder external rotation starting in 45° of internal rotation, with the arm by the side and the elbow flexed to 90 °.~Shoulder internal rotation starting in 45 ° of external rotation, with the arm by the side and the elbow flexed to 90 °..~Shoulder abduction (scapular plane) through a 0- to 60-° with the elbow flexed 90 ° and the shoulder in neutral rotation.~Shoulder flexion (sagittal plane) through a 0- to 60-°starting with the elbow flexed 90 ° and the shoulder in neutral rotation and punching forward, simultaneously extending the elbow and flexing the shoulder.~Internal rotation towel stretch: Subjects will be instructed to sit or stand while holding a towel with the affected arm behind the back and to use the other arm to pull the affected arm up the back.
Study NCT05230511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactobacillus RhamnosusGG
Description: LGG® (Culturelle Probiotic LGG®) will be used. This is the product we have used in the past and for which we have demonstrated safety, tolerability, and preliminary efficacy. For the LGG® instillation, participants will be instructed to mix the contents of 1 LGG® capsule into 45 cc sterile 0.9% saline. After mixing, participants will draw up the 45cc liquid LGG® mixture into a 60cc syringe and instill via the intermittent catheter after the last catheterization prior to going to bed. Participants will be asked to return any remaining capsules at the end of the study. Participants will be instructed to complete the USQNB-IC at the time of symptoms (in real time), and then continue completing the USQNB-IC at the determined frequency for the phase.
Study NCT05230511 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Saline bladder wash
Description: Participants will draw up the 45cc of normal saline into a 60cc syringe and instill via the intermittent catheter after the last catheterization prior to going to bed after trigger symptoms occur. Participants will be instructed to complete the USQNB-IC at the time of symptoms (in real time), and then continue completing the USQNB-IC at the determined frequency for the phase.
Study NCT06453382 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural change modification, Screening, NCD related knowledge practice and attitude
Description: The investigators will provide periodic training regarding the control and prevention of NCDs to the stakeholders. The investigators will provide WHO-Package of Essential Non-Communicable Diseases (PEN) protocol training to the stakeholders involved in healthcare service delivery. The investigators will equip the government healthcare facilities with the equipment needed for the screening of NCDs. For the stakeholders who are not directly involved with healthcare service delivery, the investigators will train them about the 5 NCDs (diabetes, hypertension, chronic respiratory disease, cancer, and mental illness) and the 5 NCD risk factors (unhealthy diet, inadequate physical activity, tobacco cessation, alcohol cessation, and air pollution). The investigators will also share information, education, and communication (IEC) materials with the stakeholders, and then they will share the information with the community.
Study NCT04944771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capivasertib
Description: Participants will receive single oral dose of capivasertib on Day 1 for Treatments A, B, C, D, E and F.
Study NCT04944771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: Participants will receive twice daily oral doses of rabeprazole for 3 days (Days -3 to -1) and a single dose on the morning of Day 1 for Treatment C.
Study NCT05545592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low oestrogen dosage
Description: From the second day of the menstrual cycle, femoston (estradiol tablets) were orally taken 2 mg q.d.. The endometrial thickness and serum oestrogen and progesterone levels were monitored on the 12th to 14th days of the menstrual cycle.
Study NCT06149923 — intervention group
Intervention type: GENETIC
Intervention: quantitative Real-time PCR
Description: : quantitative real time PCR using 7500 fast real time PCR (Applied Biosystems
Study NCT05516160 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: diagnostic of optical aberrations
Description: diagnostic of optical aberrations with new device
Study NCT05516160 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: diagnostic of optical aberrations
Description: diagnostic of optical aberrations with new device
Study NCT05186987 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05186987 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05186987 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05186987 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05153447 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M-Tech
Description: M-Tech involves the use of a mobile app delivery platform to several interventions. The components of M-Tech include: 1) Hybrid in-person and telehealth visits with oncology providers; 2) Disease-specific education videos; 3) Activity level monitoring via a wearable device with promotion of physical activity; 4) Symptom monitoring with provision of self-management strategies, and 5) Medication management.
Study NCT05153447 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants randomized to the usual care arm will receive standard of care.
Study NCT04991272 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: prewarming and warmed fluid infusion
Description: prewarming with forced air warming system and warmed fluid infusion.
Study NCT05408117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 5-0 Polypropylene epidermal suture
Description: Split-wound, intra-individual comparison - half of wound will receive 5-0 polypropylene epidermal suture and half of wound will receive 5-0 fast gut epidermal suture
Study NCT05408117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 5-0 Fast gut epidermal suture
Description: Split-wound, intra-individual comparison - half of wound will receive 5-0 polypropylene epidermal suture and half of wound will receive 5-0 fast gut epidermal suture